Results 41 to 50 of about 19,884 (261)

Acute renal failure by rapidly progressive glomerulonephritis with IgA deposition in a patient concomitantly diagnosed with multibacillary Hansen's disease: a case report

open access: yesBrazilian Journal of Nephrology, 2018
Rapidly progressive glomerulonephritis (RPGN) is a renal disease with an extensive differential diagnosis. This paper reports the case of a 55-year-old female patient diagnosed with Hansen's disease with acute progressive renal impairment after ...
Yuri de Deus Mont'alverne Parente   +5 more
doaj   +1 more source

Anti-Glomerular Basement Membrane Disease in a 10-year-old Child: A Case Report

open access: yesJournal of Nepal Medical Association, 2023
Anti-glomerular basement membrane disease is an extremely uncommon entity in children. It has an incidence of 0.5 to 1 per million per year in adults and is even more uncommon in children.
Md Firoz Anjum   +4 more
doaj   +1 more source

Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study

open access: yesIndian Journal of Pathology and Microbiology, 2012
Context: The need to perform reporting of renal biopsies of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides in a more uniform manner required relook at our eight-year data.
Ranjana W Minz   +7 more
doaj   +1 more source

Membranoproliferative glomerulonephritis in patients with chronic venous catheters: a case report and literature review. [PDF]

open access: yes, 2014
Chronic indwelling catheters have been reported to be associated with membranoproliferative glomerulonephritis (MPGN) via the activation of the classical complement pathway in association with bacterial infections such as coagulase negative ...
Nast, Cynthia C   +3 more
core   +2 more sources

Overlapping Syndromes: Drug-Induced Vasculitis From Hydralazine With Positive Antinuclear Antibodies

open access: yesClinical Medicine Insights: Case Reports, 2023
Hydralazine is an antihypertensive medication that has been associated with drug-associated autoimmune syndromes like interstitial lung disease, pauci-immune glomerulonephritis, and hypocomplementemia.
Lakshmi Kannan, UmmeRubab Syeda
doaj   +1 more source

Anca-positive vasculitis with full-house nephropathy, an unusual association: a case report and review of literature

open access: yesBrazilian Journal of Nephrology, 2021
Rapidly progressive glomerulonephritis is a medical emergency, with mortality around 20%. It is characterized by crescent glomerulonephritis and progressive loss of kidney function, hematuria, and proteinuria.
Carlos Mauricio Martínez Montalvo   +4 more
doaj   +2 more sources

A rare case of renal thrombotic microangiopathy associated with Castleman’s disease [PDF]

open access: yes, 2017
BACKGROUND: Castleman’s disease (CD) is an uncommon, heterogeneous lympho-proliferative disorder leading to high circulating levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF).
Chen, Ying Maggie   +3 more
core   +2 more sources

Rapidly Progressive Glomerulonephritis: Etiology, Treatment, and Prognosis: A Review Literature [PDF]

open access: yesTranslational Research in Urology
Rapidly progressive glomerulonephritis (RPGN) is define the following: 1. Fast damage of kidney function temporary (days to weeks). 2. Macro or microscopic hematuria, proteinuria, dysmorphic red blood cells (RBC). 3. Renal biopsy showed cellular crescent
Ziba Aghsaeifard, Setareh Zahedian
doaj   +1 more source

Rapidly progressive glomerulonephritis in adolescents – aetiology and treatment based on case reports

open access: yesPediatria i Medycyna Rodzinna, 2017
Rapidly progressive glomerulonephritis is a disease characterised by an abrupt drop in glomerular filtration rate in a short period of time, which is caused by crescent formation seen in at least 50% of glomeruli.
Beata Banaszak   +3 more
doaj   +1 more source

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome [PDF]

open access: yes, 2018
Hydralazine, a vasodilator, is commonly used as an adjunctive treatment for moderate to severe hypertension, heart failure and hypertensive emergencies in pregnancy. Hydralazine-induced lupus was first described in 1953. Clinical presentation ranges from
Aeddula, Narothama Reddy   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy